Jade Biosciences, Inc. Common Stock (JBIO) Q1 2025 Earnings
JBIO·Reported April 25, 2025·Before market open
Diluted EPS came in at $-0.09, beat the $-8.40 consensus by $8.31.
Diluted EPS
$-0.09beat by $8.31
Consensus: $-8.40
Financial Snapshot
Trailing eight quarters through Q1 2025
Q1 2025 Earnings FAQ
Common questions about Jade Biosciences, Inc. Common Stock's Q1 2025 earnings report.
Jade Biosciences, Inc. Common Stock (JBIO) reported Q1 2025 earnings on April 25, 2025 before market open.
Jade Biosciences, Inc. Common Stock reported diluted EPS of $-0.09 for Q1 2025.
EPS beat the consensus estimate of $-8.40 by $8.31.
You can read the 10-Q periodic report (0001558370-25-005564) directly on SEC EDGAR. The filing index links above go to sec.gov.